Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million
05/05/2026 21:05
May 05 (Reuters) - Trevi Therapeutics Q1 operating expenses USD 14.912 million. Q1 income from operations USD -14.912 million Q1 EPS USD -0.09 Q1 pretax profit USD -13.212 million
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million